Stockscreener 앱 받기
33.28
2.05%
0.67
시장 영업 전:
33.19
-0.09
-0.27%
Axogen Inc 주식(AXGN)의 최신 뉴스
Do options traders know something about Axogen stock we don't? - MSN
This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth - AOL.com
Axogen Insider Sale of 5,221 Shares Follows 20% Revenue Growth in 2025. Here's What to Know - The Motley Fool
DAFNA Capital Management Sells Axogen Shares in 2025News and Statistics - IndexBox
This $6.5 Million Healthcare Reduction Follows a 71% Increase in Stock Price and 20% Rise in Revenue - Bitget
AxoGen, Inc. (NASDAQ:AXGN) Q4 2025 earnings call transcript - MSN
Is Axogen (AXGN) Fairly Priced After Strong 72.7% One Year Share Gain - Yahoo Finance
Axogen chief innovation officer DeVinney sells $171k in shares By Investing.com - Investing.com Australia
Axogen chief innovation officer DeVinney sells $171k in shares - Investing.com
Erick Wayne Devinney Sells 5,221 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat
Axogen (AXGN) officer nets shares after RSU vesting and sale - Stock Titan
Axogen (AXGN) CFO nets shares from 9,000 RSU vesting as company withholds stock for taxes - Stock Titan
AxoGen Q4 2025 earnings preview - MSN
Do Options Traders Have Insights on Axogen Stock That We're Unaware Of? - Bitget
Do Options Traders Know Something About Axogen Stock We Don't? - TradingView
(AXGN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
AxoGen, Inc. $AXGN is First Light Asset Management LLC's Largest Position - MarketBeat
ArrowMark Colorado Holdings LLC Buys 332,498 Shares of AxoGen, Inc. $AXGN - MarketBeat
Citizens Maintains Axogen (AXGN) Market Outperform Recommendation - MSN
AXGN SEC FilingsAxogen Inc 10-K, 10-Q, 8-K Forms - Stock Titan
A Look At Axogen (AXGN) Valuation After AVANCE BLA Approval And Updated Growth Outlook - simplywall.st
AxoGen Says BLA Approval Secures Avance Use, Boosts Coverage Talks and Reimbursement Momentum - MarketBeat
Lake Street Initiates Coverage of Axogen (AXGN) with Buy Recommendation - MSN
Axogen at Citizens Life Sciences Conference: Strategic Growth Insights By Investing.com - Investing.com Nigeria
Axogen at Citizens Life Sciences Conference: Strategic Growth Insights - Investing.com
AxoGen Q3 2025 Earnings Preview - MSN
AxoGen Conference: AVANCE BLA Approval, Debt Paydown Fuel 2026 Growth Target of 18%+ - MarketBeat
Should Axogen’s 2026 Growth Guidance Amid Wider Losses Require Action From Axogen (AXGN) Investors? - simplywall.st
AxoGen at Leerink Conference: Strategic Growth and Market Expansion By Investing.com - Investing.com Nigeria
AxoGen at Leerink Conference: Strategic Growth and Market Expansion - Investing.com India
Chipmakers Recap: Is Axogen Inc in a bullish channel2026 Analyst Calls & Accurate Entry/Exit Alerts - baoquankhu1.vn
Royce & Associates LP Purchases New Shares in AxoGen, Inc. $AXGN - MarketBeat
(AXGN) Risk Channels and Responsive Allocation - Stock Traders Daily
AxoGen Touts FDA BLA Win, Targets 18% Growth and Wider Nerve Repair Adoption - National Today
AxoGen Touts FDA BLA Win, Targets 18% Growth and Wider Nerve Repair Adoption at Raymond James Conference - MarketBeat
AxoGen, Inc. $AXGN Shares Acquired by First Eagle Investment Management LLC - MarketBeat
AXGN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Roubaix Capital LLC Purchases New Position in AxoGen, Inc. $AXGN - MarketBeat
Axogen (AXGN) CMO granted 23,000 RSUs and adjusts share holdings - Stock Titan
Axogen (AXGN) innovation chief reports stock awards and tax-share withholding - Stock Titan
Axogen (NASDAQ: AXGN) EVP reports RSU vesting and tax share withholding - Stock Titan
AxoGen, Inc. (NASDAQ:AXGN) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Axogen, Inc. Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Axogen, Inc. Rings the Opening Bell - Nasdaq
1.53%
자본화:
|
볼륨(24시간):